North Bethesda, MD, United States of America

Martin W Skarzynski


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Martin W Skarzynski: Innovator in Cancer Research

Introduction

Martin W Skarzynski is a notable inventor based in North Bethesda, MD, with a focus on cancer research. He holds two patents that contribute significantly to the field of immunology and cancer treatment. His work is characterized by innovative approaches to targeting cancer cells.

Latest Patents

Skarzynski's latest patents include an anti-C3d antibody or antibody fragment, which targets cell surface deposited complement protein C3d. This invention outlines methods for using the antibody to kill cancer cells, along with related methods and compositions. The dual focus on both the antibody and its application in cancer treatment showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, Martin W Skarzynski has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Virginia. His experience in these institutions has allowed him to contribute to significant advancements in health and medicine.

Collaborations

Skarzynski has collaborated with esteemed colleagues, including Adrian U Wiestner and Margaret A Lindorfer. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer therapies.

Conclusion

Martin W Skarzynski's contributions to cancer research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new treatments and advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…